Hospital del Mar -ko ikertzaileekin lankidetzan egindako argitalpenak (15)

2022

  1. Sex Differences in Plasma Lysophosphatidic Acid Species in Patients with Alcohol and Cocaine Use Disorders

    Brain Sciences, Vol. 12, Núm. 5

2020

  1. Potential association of plasma lysophosphatidic acid (LPA) species with cognitive impairment in abstinent alcohol use disorders outpatients

    Scientific Reports, Vol. 10, Núm. 1

  2. Validation of the Neuronorma battery for neuropsychological assessment in multiple sclerosis

    Multiple Sclerosis and Related Disorders, Vol. 42

2019

  1. Inflammatory mediators and dual depression: Potential biomarkers in plasma of primary and substance-induced major depression in cocaine and alcohol use disorders

    PLoS ONE, Vol. 14, Núm. 3

  2. Plasma concentrations of oleoylethanolamide in a primary care sample of depressed patients are increased in those treated with selective serotonin reuptake inhibitor-type antidepressants

    Neuropharmacology, Vol. 149, pp. 212-220

2018

  1. Increased plasma oleoylethanolamide and palmitoleoylethanolamide levels correlate with inflammatory changes in alcohol binge drinkers: the case of HMGB1 in women

    Addiction Biology, Vol. 23, Núm. 6, pp. 1242-1250

  2. PPARα/CB1 receptor dual ligands as a novel therapy for alcohol use disorder: Evaluation of a novel oleic acid conjugate in preclinical rat models

    Biochemical Pharmacology, Vol. 157, pp. 235-243

2017

  1. Plasma chemokines in patients with alcohol use disorders: Association of CCL11 (Eotaxin-1) with psychiatric comorbidity

    Frontiers in Psychiatry, Vol. 7, Núm. JAN

  2. Plasma concentrations of oleoylethanolamide and other acylethanolamides are altered in alcohol-dependent patients: effect of length of abstinence

    Addiction Biology, Vol. 22, Núm. 5, pp. 1366-1377

2016

  1. Can symptoms help in differential diagnosis between substance-induced vs independent psychosis in adults with a lifetime diagnosis of cocaine use disorder?

    Psychiatry Research, Vol. 242, pp. 94-100

2015

  1. Plasma Concentrations of BDNF and IGF-1 in abstinent cocaine users with high prevalence of substance use disorders: Relationship to psychiatric comorbidity

    PLoS ONE, Vol. 10, Núm. 3

  2. Plasma profile of pro-inflammatory cytokines and chemokines in cocaine users under outpatient treatment: Influence of cocaine symptom severity and psychiatric co-morbidity

    Addiction Biology, Vol. 20, Núm. 4, pp. 756-772

  3. Sex differences in psychiatric comorbidity and plasma biomarkers for cocaine addiction in abstinent cocaine-addicted subjects in outpatient settings

    Frontiers in Psychiatry, Vol. 6, Núm. FEB

2014

  1. Assessment of the psychotherapeutic effects of ritual ayahuasca use on drug dependency: A pilot study

    The Therapeutic Use of Ayahuasca (Springer-Verlag Berlin Heidelberg), pp. 183-196

2013

  1. Evaluation of plasma-free endocannabinoids and their congeners in abstinent cocaine addicts seeking outpatient treatment: Impact of psychiatric co-morbidity

    Addiction Biology, Vol. 18, Núm. 6, pp. 955-969